IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Altamira Therapeutics LTD (CYTOF)

CUSIP: G0360L209 | Healthcare · Biotechnology | Micro Cap | 13 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Armistice Capital, LLC829,000
0.0% of portfolio›$202.7K
Citadel Advisors LLC39,165
0.0% of portfolio›$9.4K
Susquehanna International Group, LLP10,185
0.0% of portfolio›$2.5K
XTX Topco Ltd10,131
0.0% of portfolio›$2.4K
Morgan Stanley500
0.0% of portfolio›$122
Group One Trading LLC298
0.0% of portfolio›$72
Wells Fargo & Company25
0.0% of portfolio›$6
Cutler Group LP10
0.0% of portfolio›$0
Stonebridge Capital Advisors LLC5
0.0% of portfolio›$1
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Armistice Capital, LLC
829,000$202.7K0.0%GARPHighNew York, NY2023-11-14
Citadel Advisors LLC
39,165$9.4K0.0%CoreVery HighMiami, FL2023-11-14
Susquehanna International Group, LLP
10,185$2.5K0.0%GrowthHighBala Cynwyd, PA2023-11-14
XTX Topco Ltd
10,131$2.4K0.0%ValueVery HighLondon, United Kingdom2023-11-13
Morgan Stanley
500$1220.0%CoreLowNew York, NY2023-11-15
Group One Trading LLC
298$720.0%ValueVery HighChicago, IL2023-11-09
Wells Fargo & Company
25$60.0%CoreLowSan Francisco, CA2023-11-13
Cutler Group LP
10$00.0%N/AN/ASan Francisco, CA2023-11-07
Stonebridge Capital Advisors LLC
5$10.0%CoreLowSt Paul, MN2023-11-15
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-10-30